US Stock MarketDetailed Quotes

BRNS Barinthus Biotherapeutics

Watchlist
  • 1.545
  • 0.0000.00%
Close Jul 16 16:00 ET
60.31MMarket Cap-844P/E (TTM)

Barinthus Biotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Barinthus Biotherapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

0.00

-100.00%
EPS(YoY)

-0.40

+16.67%
Analyst Rating

Strong Buy

Jun 30, 2024

Barinthus Biotherapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 128.750K--
--2023/Q30.000 / 250.000K--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 128.750K--
--2023/Q30.000 / 250.000K--

Unlock Free Earnings Estimates

Barinthus Biotherapeutics Earnings Reports

  • Barinthus Biotherapeutics | 10-Q: Quarterly report

    May 13 08:19 ET

  • Barinthus Biotherapeutics | 10-K: Annual report

    Mar 20 16:29 ET

  • Barinthus Biotherapeutics: Q3 2023 Earnings Report

    Nov 9, 2023 16:18 ET

  • Vaccitech | 10-Q: Q2 2023 Earnings Report

    Aug 10, 2023 08:47 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jun 30, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg